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Self-report questionnaires are economical instruments for routine outcome assessment. In this study, the performance of the
German version of the Outcome Questionnaire-45 (OQ-45) and the Brief Symptom Inventory (BSI) was evaluated when applied
in analysis of the outcome quality of psychiatric and psychotherapeutic interventions. Pre-post data from two inpatient samples
(𝑁 = 5711) and one outpatient sample (𝑁 = 239) were analyzed. Critical differences (reliable change index) and cut-off points
between functional and dysfunctional populations were calculated using the Jacobson and Truax method of calculating clinical
significance. Overall, the results indicated that the BSI wasmore accurate than the OQ-45 in correctly classifying patients as clinical
subjects. Nonetheless, even with the BSI, about 25% of inpatients with schizophrenia attained a score at admission below the clinical
cut-off. Both questionnaires exhibited the highest sensitivity to psychopathology with patients with personality disorders. When
considering the differences in the prescores, both questionnaires showed the same sensitivity to change. The advantage of using
these self-report measures is observed primarily in assessing outpatient psychotherapy outcome. In an inpatient setting two main
problems—namely, the low response rate and the scarce sensitivity to psychopathology with severely ill patients—limit the usability
of self-report questionnaires.
1. Introduction
Along with accessibility to services, appropriateness of treat-
ment, and perception of care, outcome is an important quality
indicator in mental health care [1]. A widely used approach
to assess outcome quality is measuring symptom reduction
through rating scales, either clinician-administered or self-
reported. Self-report scales are widely used in outcome eval-
uation of psychotherapies [2].Their standardized form allows
easy administration by clinicians without additional training
and also guarantees a high level of reliability. On the other
hand, for patients with a high degree of psychopathology,
clinician-administered scales are preferred [3], for with these
scales, the psychological status of each patient can be assessed
independently of the person’s capability or willingness to
accurately describe their relevant symptoms and behaviors.
However, achieving good rating quality requires clinician
training in the application of these instruments plus subse-
quent assessment of interexaminer reliability. Given that in
general psychiatric hospitals it has been proven to be quite
difficult to routinely involve clinicians in training courses, the
question arises as to whether clinician-rated assessments can
be substituted by similar scales filled out by psychotherapy
patients themselves (self-report) [4].
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For general assessment of mental health symptoms, one
of the frequently suggested multidimensional self-report
instruments is the Symptom Checklist (SCL-90R) or its short
form, the Brief Symptom Inventory (BSI) [5–7]. However,
based on the number of published studies implementing
these questionnaires, it can be asserted that in the field
of mental health they have been used predominantly with
outpatients and far less frequently with inpatients or, more
generally, with patients with severe mental illness [8–10].
Nevertheless, these instruments seem promising in assessing
the mental health status of the latter patient group, because
they also contain specific scales for measuring psychotic and
schizotypal symptoms, such as the Psychoticism or the Para-
noid Ideation scale. However, the validity of these scales has
not as yet been unequivocally confirmed. Wood [11] found
no evidence that patients with schizophrenia score higher on
the Psychoticism scale than patients without schizophrenia.
Johnson et al. [12] found no differences on the Paranoid
Ideation and Psychoticism scales between patients diagnosed
with or without schizophrenia. In contrast, Preston and
Harrison [13] demonstrated in a sample of 69 patients
presenting their first psychotic episode that responses on the
BSI items could discriminate between patients with weak and
with marked positive symptoms.
Another instrument recommended for assessment of
individuals seeking mental health treatment is the Out-
come Questionnaire-45 (OQ-45) [14–16]. It is a newer, self-
report outcomemeasure created primarily for psychotherapy
patients, which has already been used in psychiatric inpatient
care [17, 18].
In the context of quality assurance programs, quantitative
data collected via mental health questionnaires find their
application in the analysis of pre-post differences, which
reflect the intraindividual changes attained during the treat-
ment. One widely used analysis method is the calculation
of clinical significance proposed by Jacobson and Truax
[19]. The aim of the method is to identify which patients
move outside the range of the dysfunctional population
and consequently attain “normal” functioning. Patients who
improve significantly and cross a well-defined cut-off score
between dysfunctional and functional distributions are clas-
sified as “remitted.” However, patients can only be consis-
tently classified in this way if the self-report measurement at
the beginning of the treatment correctly identifies them as
dysfunctional.
The objective of this study was to evaluate the German
versions of the OQ-45 and the BSI when applied in the analysis
of outcome quality of inpatient and outpatient treatments. The
analyses focused on three aspects of usability:
(1) Response Rate. How many patients fill out the ques-
tionnaires? To produce a representative outcome
estimation, the majority of the patients should be
able to fill out the self-report forms. A high rate of
nonresponse increases the risk of bias in the results.
(2) Sensitivity to Psychopathology. Applying the cut-
off scores calculated with the Jacobson and Truax
method, what percentages of patients are correctly
classified by the self-report measures at admission as
belonging to the dysfunctional population?
(3) Sensitivity to Change. Do the two questionnaires have
the same sensitivity to change? The equivalence of
the two measures is not obvious, since compared to
the BSI, the OQ-45 contains fewer symptom-specific
items and focuses partially on social functioning
(e.g., work), which requires more time for change to
occur than the time required to see change in acute
symptoms.
2. Methods
2.1. Samples. Three different samples, two inpatient sam-
ples and one outpatient sample, were used for this study.
Both inpatient samples were treated at an inpatient clinic
in Switzerland, the Integrated Psychiatric Services of Win-
terthur, and Zurich Unterland (ipw).
At the ipw, the OQ-45 was implemented as a self-report
measure of outcome quality from 2008 to 2010; it was
replaced by the BSI starting in 2012. For samples 1 and 2,
inpatient treatments from 2008 to 2009 (OQ-45) and from
2012 and 2013 (BSI) were selected from the database using the
following inclusion criteria:
(i) A principal diagnosis belonging to one of these major
groups: F1 (substance abuse), F2 (schizophrenia or
other psychotic disorders), F3 (mood disorders), F4
(anxiety or stress related disorders), and F6 (person-
ality disorders).
(ii) Age of at least 18 years.
(iii) Hospitalization of at least 7 days.
Sample 3 was recruited in a project on outpatients promoted
by the Swiss Charta for Psychotherapy. The aim of this
nonrandomized field study is to investigate various process-
outcome aspects of outpatient treatments carried out with
different experiential or psychodynamic therapy methods
[26–28]. Cases from this sample were selected using the
following criteria:
(i) At least one Axis I disorder according to the criteria
of DSM-IV.
(ii) Age of at least 18 years.
(iii) Minimum of 10 treatment sessions.
Both studies above were carried out in accordance with the
ethical principles of the Declaration of Helsinki. For the
Swiss Charta project, a research application was submitted
to the ethics committee of each of the Swiss cantons in
which the projects were carried out; all of the applications
were approved. All patients gave informed written consent
for their participation in the study. Data from the ipw were
collected within an internal quality measurement system
for which, according to Swiss federal and cantonal law, no
ethical approval was required. For this reason, the present
study was granted an exemption from the requirement for
ethics approval by the Cantonal Ethics Committee of Zurich
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Table 1: Descriptive statistics of the analyzed samples.
Sample 1
(𝑁
1
= 2894)
Sample 2
(𝑁
2
= 2877)
Sample 3
(𝑁
3
= 239)
Sex
Female 1424 (49.2%) 1532 (53.2%) 162 (67.8%)
Male 1470 (50.8%) 1345 (46.8%) 77 (32.2%)
Education
Low 1005 (34.7%) 895 (31.1%) 24 (10.0%)
Middle 1461 (50.5%) 1488 (51.7%) 86 (36.0%)
High 428 (14.8%) 494 (17.2%) 129 (54.0%)
Income
Salary 729 (25.2%) 687 (23.9%) 185 (77.4%)
Sickness/disability benefit 1060 (36.6%) 1147 (39.9%) 23 (9.6%)
Social welfare payments 425 (14.7%) 373 (13.0%) 3 (1.3%)
Old age insurance 232 (8.0%) 292 (10.1%) 7 (2.9%)
Other 448 (15.5%) 378 (13.1%) 21 (8.8%)
GAF 47.0 (17.2) 38.5 (14.3) 60.5 (13.1)
Principal diagnosis (ICD-10/DSM-IV)
F1: 884 (30.6%) F1: 594 (20.6%) Mood: 107 (44.8%)
F2: 681 (23.5%) F2: 649 (22.6%) Anxiety: 65 (27.2%)
F3: 706 (24.4%) F3: 927 (32.2%) Adjustment: 45 (18.8%)
F4: 386 (13.3%) F4: 461 (16.0%) Other: 22 (9.2%)
F6: 237 (8.2%) F6: 246 (8.6%)
Duration of treatment 36.7 days (38.1) 36.0 days (31.7) 41.3 sessions (34.2)
Type of discharge
Mutual consent 2327 (80.4%) 2489 (86.5%) 180 (75.3%)
Decided by the patient 221 (7.6%) 117 (4.1%) 46 (19.2%)
Decided by the treating person 215 (7.4%) 181 (6.3%) 11 (4.6%)
Other 131 (4.6%) 90 (3.1%) 2 (0.1%)
(Waiver number 09-2016). Participating patients at the ipw
gave informed verbal consent for the use of the data.
Table 1 presents the characteristics of the three samples.
In the inpatient samples 1 and 2 the most frequent substance-
related disorder (F1) was associated with alcohol consump-
tion (71.5% of the patients with an F1 diagnosis in sample
1 and 56.2% in sample 2, resp.). In the F2 group paranoid
schizophrenia was prominent (61.8% and 59.3%, resp., of
the F2 group). Most of the patients with a mood disorder
had either a depressive episode (53.2% and 51.0% within the
F3 group) or a recurrent depressive disorder (40.3% and
45.4% within the F3 group). The most frequently diagnosed
personality disorder was of the Borderline type (64.6% and
53.6% within the F6 group). In the outpatient setting, 69.2%
of diagnosed mood disorders were major depressions. The
most frequent anxiety disorders in this setting were social
phobia, panic disorder/agoraphobia, and generalized anxiety
disorder.
2.2. Measures. The following self-report and clinician-
administered instruments were used for this analysis:
(i) Basic Documentation. Important clinical information
and sociodemographic characteristics were recorded
on a form. These data were collected by the treating
psychiatrists (for inpatients) and the treating psy-
chotherapists (for outpatients).
(ii) ICD-10. Diagnoses based on this system were avail-
able for the inpatient samples and had been assigned
by the treating psychiatrists.
(iii) Structured Clinical Interviews for DSM-IV (SCID-I/-
II) [29]. These interviews, which were available only
for sample 3, served in assessing Axis I and II dis-
orders (clinical syndromes and personality disorders)
according to the DSM-IV criteria. Trained psycholo-
gists (not involved in treatment of the patients) were
engaged to carry out the two clinical interviews.
(iv) Clinical Global Impressions (CGI) [30]. This instru-
ment gathers the clinician’s view of the severity of
psychopathology (CGI-S) and of the improvements
from the initiation point of the treatment (CGI-I).
The two aspects are each rated on a 7-point scale.
Ratings with this instrument were available only
for the inpatient samples and were provided by the
treating psychiatrists.
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(v) Global Assessment of Functioning (GAF) [31]. On this
scale psychological, social, and occupational func-
tioning are rated on a hypothetical continuum from
severe mental illness (0) to mental health (100).
(vi) OQ-45. The questionnaire consists of 45 items
grouped in the three scales Symptom Distress (SD),
Interpersonal Relations (IR), and Social Role (SR),
which add up to a total score (OQ Total Score). The
scale structure of the original version is supported by
confirmatory factor analysis [14]. The single scales in
the German version exhibit good internal consistency
[20].
(vii) BSI. This questionnaire is the short version of the
SCL-90R [6]. The 53 items assess nine primary
symptom dimensions: Somatization (SOM),
Obsessive-Compulsiveness (OBS), Interpersonal
Sensitivity (INS), Depression (DEP), Anxiety (ANX),
Hostility (HOS), Phobic Anxiety (PHOB), Paranoid
Ideation (PAR), and Psychoticism (PSY). Additional
global indices of distress can be obtained, for
example, the General Symptom Index (GSI), which
is the mean score of all items. In the analysis carried
out by Derogatis and Melisaratos [5] seven of the
primary scales showed a clear convergence with their
counterparts among the MMPI scales. All scales in
the German version exhibit satisfactory test-retest
reliability [22].
2.3. Statistical Analysis
2.3.1. Missing Data. Nonresponse is a common problem in
surveys and can occur for single items or for the entire
examination. Analyzing only data of patients that responded
to every item on the self-report measures at admission as well
as at discharge would lead to a substantial loss of information,
especially for the analyses for the inpatient setting. To include
asmany cases as possible, we defined different inclusion crite-
ria for each analysis (Figure 1). First, we defined the minimal
number of answered items to calculate scale scores. In a
previous unpublished study we tested (through simulations)
the impact of incomplete item values in the calculation of
scores for theOQ-45 scales. Our results showed that if, for the
three scales, namely, SD, IR, and SR, at least 8, 6, and 6 items,
respectively, had a valid value, then the generated scale scores
preserved a correlation of 𝑟 > 0.90 with the corresponding
scores based on completely observed values. In this study, we
considered as evaluable only data records that fulfilled the
rule mentioned above. Concerning the BSI, we analyzed only
returned questionnaireswith at least 40 valid item values [32].
We calculated the response rate on the basis of the
number of returned questionnaires that fulfilled the above-
mentioned criteria of completeness. Patients who completed
a sufficient number of items at admission were included in
the analysis of sensitivity to psychopathology. Patients who
additionally did the same at discharge were included in the
analysis of sensitivity to change.
2.3.2. Parameters of Clinical Significance. For the analysis
of intraindividual changes we applied Jacobson and Truax’s
method of calculating clinical significance [19], with which
the proportions of improved and recovered cases can be
calculated [2]. To determine these proportions, two param-
eters are needed: (1) a critical difference 𝐷, which allows
identification of individual pre-post differences that are suffi-
ciently large to be considered statistically significant (reliable
change) and (2) a cut-off 𝐶, which distinguishes scores that
are a variation of normal functioning from scores indicating
a psychopathological state. Therefore, patients exhibiting a
reduction of at least 𝐷 points from their initial impairment
score are considered “improved.” If their score additionally
falls below the cut-off𝐶, then they are considered “remitted.”
The critical difference, for example, at a confidence level
of 95%, is obtained by using the standard deviation and the
reliability coefficients of the measure:
𝐷
95% = 1.96 ⋅ SDpatient ⋅ √2 (1 − 𝑟), (1)
whereas the cut-off is calculated as a weighted midpoint
between the means of a patient and a nonpatient population
as follows:
𝐶 =
SDpatient ⋅ 𝑀nonpatient + SDnonpatient ⋅ 𝑀patient
SDpatient + SDnonpatient
. (2)
We additionally compared our parameter values with those
published in other studies on the basis of samples from
Germany.
2.3.3. Outcome Comparisons. To compare sensitivity to
change, measured with two different questionnaires within
three different samples, the following analysis techniques
were used: propensity score matching and linear mixed
modeling. Given that within the inpatient setting OQ-45
and BSI data were collected in two different samples, we
matched sample 1 and sample 2 using the propensity score
technique proposed by Rosenbaum and Rubin [33]. It is
primarily used in nonrandomized studies in order to build
equivalent samples for causal inference, but it can also be
applied to compare different survey samples [34]. In our
analysis treatment modalities were defined as the two differ-
ent questionnaires presented to the patient (BSI versus OQ-
45), and outcome was defined as the scale scores measured
at intake and at discharge and then converted either in
categories of clinical significance or in 𝑧 values. As amatching
algorithm we applied the nearest neighbor matching with a
logistic regression-based propensity score [35].The following
covariates were used in the regression equation: sex, age,
marital status, educational level, GAF and CGI, respectively,
at intake and at discharge, principal diagnosis, compulsory
treatment order, duration of treatment, and type of discharge.
Matches were formed on a 1 : 1 ratio within a caliper size of
0.1 standard deviations of the propensity score.The adequacy
of the matching procedure was checked using graphical
visualizations of the propensity score distribution; the quality
of the balance in the matched groups was examined through
the standardized difference of means of each covariate [36,
37].
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Analysis
Sensitivity to
psychopathology
Sensitivity to
change
Sample 1 (OQ-45)
884 681 706 386 237
Respondents at pre
≥20 items completed
Respondents at post
≥20 items completed
Matched
F1 F2 F3 F4 F6
186 374 230 101451
F1 F2 F3 F4 F6
Complete sample
38 138 71 2677
F1 F2 F3 F4 F6
Matched
F1 F2 F3 F4 F6
36 125 76 2984
Respondents at post
≥40 items completed
342 267 659348 127
F1 F2 F3 F4 F6
Respondents at pre
≥40 items completed
F1 F2 F3 F4 F6
Complete sample
594 649 927461 246
Response
rate
Sample 2 (BSI)
NN
NN
N N
MD AD AJD O
Complete sample
107 65 45 22
Sample 3 (OQ-45/BSI)
N
Respondents at post
≥20/≥40 items completed
80 59 35 17N
Respondents at pre
MD AD AJD O
107 65 45 22N
≥20/≥40 items completed
MD AD AJD O
90 140 51221
F1 F2 F3 F4 F6 F1 F2 F3 F4 F6
172 474 259 74192N N230
N = 2894
N = 1342
N = 732
N = 350N = 350
N = 1171
N = 1743
N = 2877 N = 239
N = 191
MD: mood
AD: anxiety
ADJ: adjustment
O: other
N = 239
Figure 1: Number of cases included in the different analyses.
Besides the comparison of the proportions of cases in the
principal categories of clinical significance classified by the
two instruments, we also analyzed the pre-post differences
using the linear mixed model; for this, the OQ-45 and BSI
scores were 𝑧-transformed.
3. Results
3.1. Response Rate. The completeness of the returned ques-
tionnaires varied between the two measures. The highest
number of unanswered items was found for the OQ-45
questionnaires returned by the inpatients. Questions on
intimate relationships but also work-related questions were
the most affected by nonresponse in sample 1. Item number
7 (“I feel unhappy in my marriage/significant relationship”)
was left out in 24% of the cases. A work-related item such
as number 12 (“I find my work/school satisfying”) had 8%
missing values. Overall, the impact of incomplete responses
in sample 1 was high: of the 1342 questionnaires evaluable at
intake only 588 (43.8%) had been completely filled out.
Nonresponse on the BSI questionnaires returned by
inpatients was not related to the content but instead to the
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Table 2: Descriptive statistics and reliability (Chronbach’s alpha) of the global scales.
OQ Total Score GSI
Inpatients (𝑛
1
= 1342) Outpatients (𝑛
3
= 239) Inpatients (𝑛
2
= 1743) Outpatients (𝑛
3
= 239)
M (SD) 78.4 (28.9) 72.0 (19.4) 1.46 (0.79) 1.06 (0.53)
Min 0 33 0 0.26
Percentiles
5 31 40 0.25 0.34
10 38 47 0.41 0.45
25 58 60 0.85 0.66
50 79 71 1.40 0.97
75 99 85 2.02 1.39
90 117 95 2.56 1.76
95 126 104 2.85 2.02
Max 159 143 3.79 2.78
𝛼
∗ 0.95 0.91 0.97 0.95
Note: ∗Calculations of 𝛼 are based on complete case analysis. OQ-45 from sample 1: 𝑛1 = 588. OQ-45 from sample 3: 𝑛3 = 198. BSI from sample 2: 𝑛2 = 1282.
BSI from sample 3: 𝑛3 = 237.
Table 3: Statistics of the OQ-45 and the BSI/SCL-90R based on samples from Germany.
Functional population
M (SD)
Dysfunctional population
Cut-off Critical differenceOutpatients
M (SD)
Inpatients
M (SD)
OQ Total Score 46.2 (18.5) [20] 71.8 (21.9) [21] 79.0 (27.9) [18]∗ 58.8 [18] 17.8 [18]
GSI 0.31 (0.23) [22] 1.08 (0.63) [23] 1.47 (0.68) [24]† 0.60 [24]† 0.2 [25]
Note: ∗Pooled M and SD from the intervention and control group at admission. †Based on SCL-90R data.
position of the items. Items 1 to 10 had on average 1.5%
missing values; items above number 40 reached missingness
from 4% to 7.5%. Of the 1743 evaluable BSI forms at intake
only 1282 (73.6%) were complete.
In the outpatient sample the incompleteness of the
questionnaires was low. For the OQ-45, besides a 7% of
nonresponse on item number 7, missingness varied from 0%
to 3.5%. On the BSI questionnaires, missingness on the single
items was always under 1%.
In the inpatient setting the response rate at both pre- and
postmeasurement was about 25% for the OQ-45 in sample 1
and 40% for the BSI in sample 2. This difference has to be
viewed as improvement in data monitoring over the course
of the years and cannot be considered to be an indicator for
better acceptance of the BSI over the OQ-45.
The response rate was dependent on the severity of
psychopathology at admission and of the amount of improve-
ment at discharge in both inpatient samples (Figure 2).
Moreover, patients with schizophrenia showed the lowest
response rate, with the BSI, 41% at intake and 45% at
discharge. The highest rate was registered among patients
having an F4 diagnosis, with 75% at intake and 65% at
discharge, respectively.
In the outpatient sample the response rate at the end of
the therapy did not correlate significantly with Axis I or Axis
II diagnoses.
3.2. Cut-Off and Critical Difference. Table 2 shows the
descriptive statistics of the scales based on data collected at
the beginning of the treatment in the three samples. Table 3
reports comparative statistics from German sample 3.
The cut-off and the critical difference for the OQ Total
Score were calculated using the data of the respondents from
sample 1 at intake (𝑁 = 1342,𝑀patient = 78.4, SDpatient = 28.9,
and Chronbach’s 𝛼 = 0.95) and data published by Lambert
et al. [20] on a nonclinical sample (𝑁 = 232, 𝑀nonpatient =
46.2, and SDnonpatient = 18.5). Applying (1) and (2) led to 𝐶 =
59 and 𝐷
95% = 18. Therefore, a patient can be classified as
remitted if the following two conditions are fulfilled: (a) his
OQ Total Score has decreased by at least 18 points and (b)
has reached a value below 59 at the end of the treatment. If
only (b) ismet, then the patient is classified as improved. Both
parameter values are similar to those published in Puschner
et al. [18].
The calculation of the parameters for the GSI scale was
based on data of the respondents from sample 2 (𝑁 = 1743,
𝑀patient = 1.46, SDpatient = 0.79, and Chronbach’s 𝛼 = 0.97)
and the data published in Franke [22] on a nonclinical sample
(𝑁 = 600, 𝑀nonpatient = 0.31, and SDnonpatient = 0.23). The
corresponding parameters of clinical significance were 𝐶 =
0.57 and 𝐷
95% = 0.38. Schmitz et al. [24] obtained a similar
cut-off value based on a sample of participants with severe
impairments in which inpatient treatment was indicated.
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Missingness and severity of psychopathology at intake (CGI-S)
Missingness and level of improvement at discharge (CGI-I)
24 : 18
398 :160
972 : 570
248 : 322
21 : 55
57 : 29
402 : 299
639 : 784
11 : 55
126 : 313
Mildly ill or less Moderately ill Markedly ill Severely ill Extremely ill
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Pr
op
or
tio
n
24 : 126
132 : 211
360 : 440
731 : 501 163 : 117
128 : 120
509 : 548
276 : 559
70 : 279
25 : 142
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Pr
op
or
tio
n
Worse No change Minimally
improved
Much
improved
Very much
improved
BSI
OQ-45
Figure 2: Relationship between missingness (proportion of nonresponse) and CGI ratings. The ratio between the number of respondents
and the number of nonrespondents is noted on top of the bars (data from samples 1 and 2).
Lutz et al. [25] proposed a critical difference calculated with
the standard deviation of the functional sample, which is
consequently narrower than our value based on a commonly
larger standard deviation from a clinical sample.
3.3. Sensitivity to Psychopathology. Figures 3 and 4 report
the sensitivity of the global scales OQ Total Score and GSI.
Figure 3 shows the profiles of different diagnosis groups on
the OQ-45 scales. More than 80% of the inpatients with
diagnoses F3, F4, and F6 had an OQ Total Score of at
least 59 points and were therefore classified as clinical cases
(caseness). Fewer than 70% of inpatients with a diagnosis
F1 or F2 scored above the clinical cut-off. Considering the
most important clinical disorders in an outpatient setting,
that is, affective and anxiety disorders, fewer than 70% of
the patients with an anxiety disorder but without a comorbid
personality disorder (PD) were correctly classified as clinical
cases by OQ Total Score. In contrast, sensitivity of more than
80% was attained among patients with an affective disorder,
independently of additional comorbidity on the Axis II. Since
the SD scale contributes the most to the Total Score scale,
a high correlation of 𝑟 = 0.96 between the two scales was
present. The other two scales, that is, IR and SR, which have
a minor importance in forming the Total Score, also did not
vary substantially across the different type of disorders.
In contrast to the OQ-45, the BSI produced profiles with
more distinctive differences between the diagnosis groups
(Figure 4). Except for the patients with schizophrenia (F2),
the Depression scale was the scale with the highest score
for the different diagnosis groups. The largest mean on this
scale was exhibited by patients with a personality disorder
(F6) and not, as theoretically expected, by patients with an
affective disorder (F3). Patients with schizophrenia attained
the highest score on the Paranoid Ideation scale, whichwould
be in accordance with the diagnostic criteria for this psychi-
atric group. However, their mean score was outperformed by
that of patients with an F6 diagnosis. Overall, the highest
Symptom Distress as measured by the BSI was observed on
average among patients with a personality disorder in both
an inpatient and an outpatient setting.
In the samples of inpatients and outpatients, the BSI with
its GSI scale exhibited a higher sensitivity to psychopathology
than the OQ-45 with its Total Score scale. However, the same
diagnosis groups with a low average OQ Total Score, that is,
F2 and F1 among the inpatients and anxiety disorders without
PD among the outpatients, achieved a GSI score that was
on average also lower than that of other diagnosis groups.
About 25% of the respondents with an F2 diagnosis were not
correctly classified as clinical cases. The caseness determined
by theGSI scalewas not associatedwith theCGI orGAF score
(logistic regression: 𝜒2(2) = 0.56, 𝑝 = 0.76). Therefore, the
substantial misclassification of patients with schizophrenia
cannot be considered to be a consequence of low severity of
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Inpatients (sample 1) Outpatients (sample 3)
Respondents
F1 F2 F3 F4 F6
186 374 230 101N
MD with
PD
MD w/o
PD
Respondents
AD with
PD
AD w/o
PD
43 64 32 33N451
20
30
40
50
60
Sc
or
e
IR SRSD
Scale
20
30
40
50
60
Sc
or
e
IR SRSD
Scale
Sensitivity
F1 62.3%
F2 60.5%
F3 87.4%
F4 83.1%
F6 86.5%
85.4%
82.8%
93.4%
65.2%
Sensitivity
MD with PD
AD with PD
MD w/o PD
AD w/o PD
Figure 3: OQ-45 profiles of the respondents at intake. For sample 3 only data of patients with a principal diagnosis of mood (MD) or
anxiety disorder (AD) grouped according to the presence or absence of a personality disorder (PD) are represented. Percentages represent
the sensitivity to psychopathology according to the OQ Total Score.
mental illness or high psychosocial functioning of the sample
analyzed.
For both instruments one would actually expect to find
higher sensitivity to psychopathology with inpatients than
with outpatients, but the percentages in Figures 3 and 4 do not
support this expectation. The statistics in Table 2 show that
respondents with 0 points on one of the questionnaires were
found among the inpatients but not among the outpatients
and that the 5th and the 10th percentiles in the inpatient
samples were lower than the corresponding values from
the outpatients. The lowest 5th percentiles of the global
questionnaire scores were found for the GSI among the
inpatients with substance abuse (0.15) and inpatients with
schizophrenic disorders (0.11).
3.4. Sensitivity to Change. For the inpatient setting, we based
our analysis of sensitivity to change onmatched samples.The
histograms in Figure 5 show that samples 1 and 2 were already
quite similar before the matching, since they exhibited an
extensive overlap of their propensity score distributions but
with some density differences, however. From the smaller
sample, that is, sample 1, a total of 419 patients with complete
scales and covariates values were available for the matching.
Of these, 350 cases could successfully be matched on a
1 : 1 ratio with cases from the larger sample 2 (the absolute
standardized difference of means was smaller than 0.1 for
each covariate).
Figure 6 shows the results of the clinical significance anal-
ysis. In the outpatient sample, the proportions of improved
and remitted cases classified by the two measures were quite
similar. In the inpatient samples, the GSI scale identified 54%
improved cases compared to the 41.4% identified by the OQ
Total Score. Although this difference is significant [𝜒2(7) =
58.5, 𝑝 < 0.001], it does not necessarily attest a superior
sensitivity to change to the BSI. This is because the GSI scale
produces higher prescores than the OQ Total Score, and,
therefore, patients have a higher probability of lowering their
score on the GSI than on the OQ total scale during their
treatment.
To balance out this difference, the scores of the two
questionnaires were 𝑧-transformed and analyzed with a
linear mixed model. Figure 7 shows the estimated fixed
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effects; they indicate that the two questionnaires recorded
the same amount of change between the pre- and the
postmeasurement.
4. Discussion
This study examined the applicability of the OQ-45 and
the BSI for assessing the outcome quality of inpatient and
outpatient treatments. Both of these self-report measures can
be easily administered by awide range of service professionals
and take about 10minutes to be filled out. Normative data and
analysis results concerning their psychometric properties are
available [38].
However, our analyses pointed out the following critical
aspects of the performance of the two questionnaires, which
have often been neglected in the literature: (1) the number
of missing values that emerges in the data collection, (2) the
diagnostic value of the scale profiles, and (3) the robustness
of the clinical significance algorithm.
(1) Missing Data. Since Rubin’s [39] seminal paper on infer-
encewithmissing data, there has been a growing awareness of
this problem in the scientific community. In evaluation stud-
ies, the probability of nonresponse is often correlated with
the attained outcome. Our results clearly demonstrate this
relationship. Respondents and nonrespondents are different
in two clinically crucial aspects: nonrespondents have higher
severity of mental illness and show less improvement after
the treatment than respondents. Missingness is therefore a
source of bias when assessing the effectiveness of a treatment,
and nowadays guidelines concerning the statistical analysis
of incomplete data are available [40, 41]. Different authors
have pointed out that missingness as low as 10%, if not
treated adequately in the statistical analysis, can lead to bias
[42, 43]. In a previous analysis we were able to successfully
apply multiple imputation to the outcome data of sample
3, because, first, the missing rate in the sample was rela-
tively low (20%) and, second, the progress of the patients
was additionally monitored through repeated measurements
during the treatment, which generally improve the predictive
power of the imputation model [27]. In contrast, with
samples 1 and 2 the application ofmultiple imputation proved
to be ineffective. On the one hand, nonresponse in these
samples exceeded 50%, and according to Rubin [44] multiple
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imputation was conceived to deal with a typical fraction
of missing information of 30% or less. On the other hand,
the drastic reduction of the data collection to only pre-post
measurements, in order to minimize administrative expense,
makes it hard to obtain robust estimations of themissing data
through imputation models. All in all, the high proportion
of missing data discourages the use of self-report measures
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with the patients with severe impairments usually found in a
psychiatric hospital setting in favor of clinician-administered
measures.
(2) Diagnostic Value of the Profiles. Questionnaires like OQ-
45 and BSI have a relatively large number of items, so that
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different reliable Likert scales may be formed that allow the
creation of a person’s profile. Can these profiles be used,
for instance, to facilitate the formulation of a psychiatric
diagnosis? Our results do not support the use of these
questionnaires as screening instruments to facilitate the
assessment of ICD-10 diagnoses. In the construction of the
OQ-45 this was never an intended purpose [45], but the nine
primary symptom dimensions of the BSI suggest a possible
application for screening purposes. In our sample, inpatients
with personality disorders attained on average higher scores
than inpatients in other diagnosis groups on six of the nine
BSI scales. These patients had a higher mean score on the
Depression scale than patients with an affective disorder
and a higher mean score on the Paranoid Ideation scale
than patients with schizophrenia. Poor diagnostic efficacy
of the nine scales in assessing DSM-IV symptom disorders
was also reported by Pedereen and Karterud [46]. Two
different approaches have been suggested for dealing with
the low discriminant validity of the BSI scales. The first is
to consider the questionnaire through its GSI score as more
appropriate for measuring the overall degree of psychological
distress instead of the precise nature of the psychopathology
[38]. From this optic, the Outcome Questionnaire with 45
items in its full version or 30 items in its short version
would seem to be a more time-effective choice than BSI
when measuring general level of psychological distress in
a less time-consuming way. The second approach consists
in improving the factorial structure of the questionnaire.
To this purpose, different authors have used the bifactor
structural model in recent years. This model is used to build
a general distress factor and more specific components of
psychopathology. Thomas [47] demonstrated that a bifactor
model of the BSI items can achieve higher accuracy than an
oblique simple structure in diagnosing some disorders, such
as depression or generalized anxiety disorder. Brodbeck et
al. [48] also proposed a bifactor solution that correlates with
DSM-IV diagnoses, especially depressive disorders, anxiety
disorders, and personality disorders. One of their results in
line with ours is that patients with personality disorders are
characterized by a high level of general distress. Overall, it
seems that improving the factor structure of the BSI can
lead to improved sensitivity in identifying depressive or
anxiety disorders, but we doubt that it can do the same with
patients with substance abuse or acute psychotic disorders. A
nonnegligible part of these patients tends to score low, and
their profiles resemble those of healthy persons or remitted
patients. These results support the hypothesis that patients
with these disorders are inclined to underestimate their own
emotional and behavioral difficulties. As pointed out by
Burlingame et al. [8] the disadvantages of using self-report
measures with inpatients with severe and persistent mental
illness “include an insufficient clinical picture as a result of
the dependence on patients’ ability to accurately describe
their condition, which at times is doubtful because of denial,
minimization of symptoms, or responder bias” (p. 448).
(3) Robustness in the Outcome Evaluation. Clinical signifi-
cance, as originally proposed by Jacobson and Truax [19], is
considered, beside pre-post effect sizes, to be a gold standard
as a performance indicator in routine outcome monitoring
[49]. This approach encompasses two steps: first, identifying
the subsample of patients that reached a reliable change and
then determining which among them moved outside the
range of the dysfunctional population. This method presup-
poses a valid and consistent distinction between functionality
and dysfunctionality already at the onset of the treatment.
Therefore, the percentage of cases that can be adequately
categorized depends on the sensitivity of the instrument.
For self-report questionnaires measuring important mental
health problems, the expected sensitivity is of at least 80%
[50, 51]. Our results reveal a heterogeneous picture in this
regard. For inpatients with an F3, F4, or F6 diagnosis the
sensitivity to psychopathology of both instruments exceeds
80%. However, the questionnaires exhibited low values with
inpatients with a principal diagnosis of substance abuse
or schizophrenia. Especially within the latter group, which
represents an important diagnosis group in an inpatient
setting, about 25% of the respondents were misclassified as
nonclinical subjects according to the GSI score. The patients
with schizophrenia analyzed in this study had a mean GAF
score of 32 points at admission and were hospitalized on
average 36 days in a primary care hospital.Thus, the substan-
tial misclassification cannot be explained by a lack of mental
illness but instead by limitations, either of the measures used
in assessing psychopathology or of the methodology used
in assessing caseness. Analyses based on outpatients have
reported sensitivity of above 90% for the OQ total scale [52]
as well as the GSI scale [46]. Sensitivity values of at least
80% based on inpatient data were reported by Moessner et
al. [53] for both global scales using data from inpatients
with an F3, F4, F5, or F6 diagnosis and by Timman et
al. [54] for the OQ Total Score using an inpatient sample
with personality disorders. Nevertheless, our analyses do not
support a generalization of this high accuracy in detecting
caseness among inpatients with an F1 or F2 diagnosis. A
lack of research on the generalizability of the OQ-45 was
confirmed by Lambert and Hawkins [55], who admitted that
much of the research “demonstrating the use of the OQ-45
has been conducted with young, educated patients” (p. 496).
Concerning the limitations of ourmethodology in assess-
ing clinical significance, we see the following possibilities for
improvement: (1) construct psychological functioning scales
using a bifactor model. For both questionnaires, there are
various published results demonstrating that this kind of
factor analysis is able to improve the fit of the scale structure
to the data [47, 48, 56]; (2) determine the cut-off scores
with the receiver operating characteristic (ROC) curve. This
method can provide more accurate cut-off scores than the
weighted midpoints calculated by the Jacobson and Truax
method, especially when data are not normally distributed
[57]. The procedure requires raw data from both a healthy
and a patient sample; however, (3) avoid the necessity of cut-
off scores between functionality and dysfunctionality by using
the percentage of improvement approach. A different outcome
evaluation that could be applied as a complement to the
Jacobson andTruaxmethod consists in analysis of the relative
change from the baseline severity [58]. A reduction of at
least 50% of the initial symptom level can be considered as
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response to treatment, whereas a reduction of at least 75% is
necessary to rate the outcome as remission [59].
Concerning the comparison of the two outcome instru-
ments, the overall better accuracy of BSI in detecting clinical
cases that emerged in our analyses means that patients’
prescores are on average lower with the OQ-45 than with
the BSI questionnaire. Patients with low scores already at
the beginning obviously have on average a minor proba-
bility of further lowering their scores during the treatment,
independently of the quality of the treatment. Consequently,
this disparity between the two measures leads to a higher
sensitivity to change for the BSI.
5. Conclusion
On the whole, the comparison of the two questionnaires, BSI
and OQ-45, as instruments to be used for routine outcome
assessment leads to the following statements:
(i) In an inpatient setting both questionnaires have basi-
cally the same sensitivity to change. However, the OQ-
45 has a lower sensitivity to psychopathology than the
BSI, a characteristic that also has an impact on sensi-
tivity to change. Another drawback affecting the OQ-
45 is that inpatients tend to leave out the questions
on intimate relationships or work. Unfortunately, in
the inpatient setting, the nonresponse rate with both
self-report measures is higher than 30%, leading to
potentially nonrepresentative results.
(ii) In an outpatient setting, the superiority of the BSI in
both types of sensitivity is minimal. Therefore, OQ-
45 can be considered as an equivalent alternative
to the BSI in routine outcome monitoring, with the
advantage that it is less time-consuming.
(iii) Due to the limited sensitivity to psychopathology in
both treatment settings, it is not advisable to base clin-
ical assessment on data collected only with these self-
report questionnaires; they should be complemented
with clinician-completed ratings.
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